4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular CarcinomaDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmRecruitingPhase 12026-05-14NCT07493044
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid TumorsNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, skin neoplasmRecruitingPhase 12025-09-03NCT06942143
A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid TumorsChemically-Induced Disorders, Drug-Related Side Effects and Adverse ReactionsRecruitingPhase 12025-03-26NCT06716619
Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid TumorsChemically-Induced Disorders, Drug-Related Side Effects and Adverse ReactionsRecruitingPhase 12024-12-03NCT06302062